YSP making M’sia high-end hub for S-E Asia

PETALING JAYA: YSP Southeast Asia Holding Bhd will shift the production of lower-end generic drugs to Vietnam and transform Malaysia into a high-end manufacturing hub for South-East Asia.

President and group managing director Datuk Dr Frank Lee Fang Hsin said the proposed Dong Nai plant would focus on veterinary products and lower-end drugs while the Malaysian facility would manufacture injectables and eye-drops.